Funding infectious disease research: A systematic analysis of UK research investments by funders 1997-2010

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Fitchett, Joseph R ^a   Head, Michael G ^b   Cooke, Mary K ^b   Wurie, Fatima B ^b   Atun, Rifat ^c,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN TRYPANOSOMIASIS; ARTICLE; CAMPYLOBACTERIOSIS; CHLAMYDIASIS; EPSTEIN BARR VIRUS INFECTION; EYE INFECTION; FINANCIAL MANAGEMENT; FUNDING; GASTROINTESTINAL INFECTION; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS DISEASE RESEARCH; INFLUENZA; INVESTMENT; LYMPHATIC FILARIASIS; MEDICAL RESEARCH; MENINGITIS; RESPIRATORY TRACT INFECTION; SALMONELLOSIS; SCHISTOSOMIASIS; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; TREND STUDY; UNITED KINGDOM; COMMUNICABLE DISEASE; COOPERATION; ECONOMICS; GREAT BRITAIN; STATISTICS AND NUMERICAL DATA;

BIOMEDICAL RESEARCH; COMMUNICABLE DISEASES; COOPERATIVE BEHAVIOR; FINANCIAL SUPPORT; GREAT BRITAIN; HUMANS; INVESTMENTS;

EID: 84940311257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105722     Document Type: Article

References (23)

1. Atun R, Knaul FM, Akachi Y, Frenk J (2012) Innovative financing for health: what is truly innovative? Lancet 380: 2044-2049
2. Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, et al (2013) UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 13: 55-64
3. Fisk NM, Atun R (2009) Systematic analysis of research underfunding in maternal and perinatal health. BJOG 116: 347-356
4. Moran M, Guzman J, Henderson K, Liyanage R, Wu L, et al. (2012) G-FINDER - Neglected disease research and development: A five year review. Sydney: Policy Cures. Available: http://www.policycures.org/downloads/GF2012-Report.pdf. Accessed 12 October 2013
5. Gross CP, Anderson GF, Powe NR (1999) The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 340: 1881-1887 (Pubitemid 29272669)
6. Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, et al. (2011) NIH disease funding levels and burden of disease. PLoS One 6: e16837
7. Kyratsis Y, Ahmad R (2013) Mapping the terrain of investment in global infectious diseases. Lancet Infect Dis 13: 6-7
8. WHO (2012) Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination. Geneva: World Health Organization. Available: http://www.who.int/phi/CEWG-Report-5-April-2012.pdf. Accessed 12 October 2013
9. Røttingen J-A, Chamas C (2012) A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG). PLoS Med 9: e1001219
10. Røttingen J-A, Regmi S, Eide M, Young AJ, Viergever RF, et al. (2013) Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? Lancet 382: 1286-1307
11. WHO (2012) Draft working paper: A global health R&D observatory - developing a case for its development. Geneva: World Health Organization. Available: http://www.who.int/phi/documents/dwp1-global-health-rd-observatory- 16May13.pdf. Accessed 12 October 2013
12. Terry RF, Allen L, Gardner CA, Guzman J, Moran M, et al. (2012) Mapping global health research investments, time for new thinking-a Babel Fish for research data. Health Res Policy Syst 10: 28
13. Zachariah R, Ford N, Maher D, Bissell K, Van den Bergh R, et al. (2012) Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis 12: 415-421
14. Cobelens F, van Kampen S, Ochodo E, Atun R, Lienhardt C (2012) Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review. PLoS Med; 9: e1001358
15. Stuckler D, King L, Robinson H, McKee M (2008) WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet 372: 1563-1569
16. Katz I, Komatsu R, Low-Beer D, Atun R (2011) Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015. PLoS One 6: e17166
17. Lal SS, Uplekar M, Katz I, Lonnroth K, Komatsu R, et al. (2011) Global Fund financing of public-private mix approaches for delivery of tuberculosis care. Trop Med Int Health 16: 685-692
18. Katz I, Aziz MA, Olszak-Olszewski M, Komatsu R, Low-Beer D, et al. (2010) Factors influencing performance of Global Fund-supported tuberculosis grants. Int J Tuberc Lung Dis 14: 1097-1103
19. Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, et al. (2008) Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ 86: 27-39
20. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, et al. (2010) Funding of US biomedical research, 2003-2008. JAMA 303: 137-143
21. Dorsey ER, George BP, Dayoub EJ, Ravina BM (2011) Finances of the publishers of the most highly cited US medical journals. J Med Libr Assoc 99: 255-258
22. McCoy D, Chand S, Sridhar D (2009) Global health funding: how much, where it comes from and where it goes. Health Policy Plan 24: 407-17
23. Head MG, Fitchett JR, Atun R (2013) Global health priorities and research funding - Authors' reply. Lancet Infect Dis 13: 653